Sweden· SE-20241002000016

Ganciclovir Bioglan 500 mg Pulver till koncentrat till infusionsvätska, lösning

A medicinal product containing ganciclovir, registered in Sweden by Bioglan AB.

Checked against Swedish Medical Products Agency (Sweden) on October 1, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about ganciclovirAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

The record

At a glance

Swedish Medical Products Agency (Sweden)

Active substance: Ganciclovir
Manufacturer: Bioglan AB
Country: Sweden (SE)
ATC code: —
Reimbursed: Not published by this register
Source register: Swedish Medical Products Agency (Sweden)
Last checked: October 1, 2026

Packs & prices · 1

se_varunummer
20241002000016

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ganciclovir in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ganciclovir products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

Austria · Cymevene, Ganciclovir Oresund Pharma
Belgium · Cymevene, Virgan
Bulgaria · Ганцикловир Ромфарм
Czechia · Cymevene, Virgan
Germany · Cymeven I.V., Ganciclovir Accord
Denmark · Cymevene, Ganciclovir Oresund Pharma
Spain · Cymevene, Ganciclovir Accord
Finland · Cymevene, Ganciclovir Bioglan
France · Cymevan, Ganciclovir Hikma
United Kingdom (Northern Ireland) · Cymevene, Ganciclovir Kensington Pharma
Greece · Gancilen, Virgan
Croatia · Cymevene
Hungary · Cymevene, Ganciclovir Rompharm
Ireland · Cymevene
Italy · Citovirax, Ganciclovir Accord
Luxembourg · Cymevene, Virgan
Netherlands · Cymevene, Ganciclovir Sandoz
Norway · Cymevene, Ganciclovir Bioglan
Poland · Cymevene, Ganciclovir Accord
Portugal · Cymevene, Ganciclovir Accord
Romania · Ganciclovir Rompharm, Virgan
Slovakia · Cymevene

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c5f093b2-e178-4e66-9b32-fe6581597d9a
GET /v1/drugs/c5f093b2-e178-4e66-9b32-fe6581597d9a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "PAR",
    "SmPC",
    "PL",
    "sRMP",
    "sPAR",
    "Dispensbeslut"
  ],
  "se_npl_id": "20241002000016",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20241002000016",
  "product_doc_link": "https://docetp.mpa.se/LMF/Ganciclovir%20Bioglan%20500%20mg%20powder%20for%20concentrate%20for%20solution%20for%20infusion%20SmPC_09001bee84f9bdea.pdf"
}

API reference MCP server Plans

See everything about ganciclovir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console